WASHINGTON, Nov. 12, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that it will participate at the following upcoming investor conferences in November and December 2015.
Jim Kelly, Vanda's Senior Vice President and Chief Financial Officer, will participate at the Brean Capital 2015 Life Sciences Summit in New York City on Monday, November 16, 2015.
Mihael H. Polymeropoulos, M.D., Vanda's President and CEO, will deliver a corporate presentation at the Jefferies Autumn Global Healthcare Conference in London, England on Thursday, November 19, 2015 at 2 p.m. Greenwich Mean Time (9 a.m. Eastern Time).
Dr. Polymeropoulos will deliver a corporate presentation at the 27th Annual Piper Jaffray Healthcare Conference in New York City on Wednesday, December 2, 2015 at 2:30 p.m. Eastern Time.
The corporate presentations given by Dr. Polymeropoulos at the Jefferies and Piper Jaffray conferences will be available live on Vanda's corporate website, where they also will be archived for 30 days. To access the presentations, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentations.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.
Company Contact:
Jim Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-300178091.html
SOURCE Vanda Pharmaceuticals Inc.
Print Page